The estimated Net Worth of Lorence H. Kim is at least $27.4 Milión dollars as of 22 July 2022. Lorence Kim owns over 50,000 units of Revolution Medicines Inc stock worth over $2,520,430 and over the last 9 years Lorence sold RVMD stock worth over $24,854,422.
Lorence has made over 14 trades of the Revolution Medicines Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Lorence bought 50,000 units of RVMD stock worth $1,000,000 on 22 July 2022.
The largest trade Lorence's ever made was exercising 458,715 units of Revolution Medicines Inc stock on 6 December 2019 worth over $9,467,878. On average, Lorence trades about 55,424 units every 32 days since 2015. As of 22 July 2022 Lorence still owns at least 60,500 units of Revolution Medicines Inc stock.
You can see the complete history of Lorence Kim stock trades at the bottom of the page.
Lorence's mailing address filed with the SEC is C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DR, REDWOOD CITY, CA, 94063.
Over the last 5 years, insiders at Revolution Medicines Inc have traded over $249,645,422 worth of Revolution Medicines Inc stock and bought 3,371,315 units worth $74,500,278 . The most active insiders traders include Peter Svennilson, Thilo Schroeder a Rock Ventures Ii, L.P.Third.... On average, Revolution Medicines Inc executives and independent directors trade stock every 11 days with the average trade being worth of $3,075,216. The most recent stock trade was executed by Stephen Michael Kelsey on 13 August 2024, trading 16,667 units of RVMD stock currently worth $68,168.
revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.
Revolution Medicines Inc executives and other stock owners filed with the SEC include: